Literature DB >> 20454511

Three-dimensionally specific inhibition of DNA repair-related genes by activated KRAS in colon crypt model.

Toshiyuki Tsunoda1, Yasuo Takashima, Takahiro Fujimoto, Midori Koyanagi, Yasuhiro Yoshida, Keiko Doi, Yoko Tanaka, Masahide Kuroki, Takehiko Sasazuki, Senji Shirasawa.   

Abstract

Growth and differentiation of colonic epithelium are regulated in the three-dimensional (3D) physiological architecture, colonic crypt, and deregulation of 3D interactions is involved in tumorigenesis. Cell-based 3D culture systems provide a suitable approach bridging the gap between two-dimensional (2D) culture and animal models. KRAS mutations are found at high frequencies in human colorectal cancer (CRC); however, KRAS-targeted cancer therapy has not been developed. Here, we have established a 3D cell culture model resembling the colonic crypt by use of HKe3 cells, human CRC HCT116 cells disrupted at activated KRAS. In this 3D colonic crypt model, HKe3 cells showed the features of time course-dependent transit-amplifying and terminal-differentiated stages, which are characteristic of normal colonic crypt. On the basis of the features of HCT116 cells, activated KRAS inhibited normal cell polarity and apoptosis in 3D culture. The expression of DNA repair-related tumor suppressor genes including TP53, BRCA1, BRCA2, and EXO-1 was markedly suppressed by activated KRAS in 3D culture but not in 2D culture. These results together suggest that activated KRAS plays critical roles in the accumulation of genetic alterations through inhibition of DNA repair genes and apoptosis and that this 3D culture model will provide a useful tool for investigating the molecular mechanisms of CRC development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20454511      PMCID: PMC2864477          DOI: 10.1593/neo.10170

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  44 in total

1.  Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis.

Authors:  Tobias Schmelzle; Arnaud A Mailleux; Michael Overholtzer; Jason S Carroll; Nicole L Solimini; Eric S Lightcap; Ole P Veiby; Joan S Brugge
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-26       Impact factor: 11.205

Review 2.  Complex networks orchestrate epithelial-mesenchymal transitions.

Authors:  Jean Paul Thiery; Jonathan P Sleeman
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

3.  Basal colon crypt cells are more sensitive than surface cells toward hydrogen peroxide, a factor of oxidative stress.

Authors:  Daniela L Oberreuther-Moschner; Gerhard Rechkemmer; Beatrice L Pool-Zobel
Journal:  Toxicol Lett       Date:  2005-06-23       Impact factor: 4.372

Review 4.  Mechanisms of disease: from stem cells to colorectal cancer.

Authors:  Stuart A C McDonald; Sean L Preston; Matthew J Lovell; Nicholas A Wright; Janusz A Z Jankowski
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2006-05

Review 5.  Cell polarity in development and cancer.

Authors:  Andreas Wodarz; Inke Näthke
Journal:  Nat Cell Biol       Date:  2007-09       Impact factor: 28.824

Review 6.  Modeling tissue morphogenesis and cancer in 3D.

Authors:  Kenneth M Yamada; Edna Cukierman
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

7.  Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies.

Authors:  M Kucherlapati; A Nguyen; M Kuraguchi; K Yang; K Fan; R Bronson; K Wei; M Lipkin; W Edelmann; R Kucherlapati
Journal:  Oncogene       Date:  2007-04-23       Impact factor: 9.867

8.  ZFAT expression in B and T lymphocytes and identification of ZFAT-regulated genes.

Authors:  Midori Koyanagi; Kazuhiko Nakabayashi; Takahiro Fujimoto; Ning Gu; Iwai Baba; Yasuo Takashima; Keiko Doi; Haruhito Harada; Norihiro Kato; Takehiko Sasazuki; Senji Shirasawa
Journal:  Genomics       Date:  2008-03-07       Impact factor: 5.736

Review 9.  An oncogene-induced DNA damage model for cancer development.

Authors:  Thanos D Halazonetis; Vassilis G Gorgoulis; Jiri Bartek
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

10.  Analysis of the DNA binding activity of BRCA1 and its modulation by the tumour suppressor p53.

Authors:  Riffat Naseem; Michelle Webb
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

View more
  17 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Preclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancer.

Authors:  Flavien Devun; Guilhem Bousquet; Julian Biau; Aurélie Herbette; Christophe Roulin; Frédérique Berger; Jian-Sheng Sun; Sylvie Robine; Marie Dutreix
Journal:  J Gastroenterol       Date:  2011-11-09       Impact factor: 7.527

3.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

Review 4.  K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas.

Authors:  Nikolaos Margetis; Myrsini Kouloukoussa; Kyriaki Pavlou; Spyridon Vrakas; Theodoros Mariolis-Sapsakos
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

5.  A novel resveratrol derivative selectively inhibits the proliferation of colorectal cancer cells with KRAS mutation.

Authors:  Haruna Okamoto; Taiji Matsukawa; Satoshi Doi; Toshiyuki Tsunoda; Yuuga Sawata; Madoka Naemura; Koichiro Ohnuki; Senji Shirasawa; Yojiro Kotake
Journal:  Mol Cell Biochem       Date:  2017-09-21       Impact factor: 3.396

6.  Oncogenic Kras promotes chemotherapy-induced growth factor shedding via ADAM17.

Authors:  Sandra Van Schaeybroeck; Joan N Kyula; Audrey Fenton; Catherine S Fenning; Takehiko Sasazuki; Senji Shirasawa; Daniel B Longley; Patrick G Johnston
Journal:  Cancer Res       Date:  2010-12-10       Impact factor: 12.701

7.  Immune-related zinc finger gene ZFAT is an essential transcriptional regulator for hematopoietic differentiation in blood islands.

Authors:  Toshiyuki Tsunoda; Yasuo Takashima; Yoko Tanaka; Takahiro Fujimoto; Keiko Doi; Yumiko Hirose; Midori Koyanagi; Yasuhiro Yoshida; Tadashi Okamura; Masahide Kuroki; Takehiko Sasazuki; Senji Shirasawa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

8.  RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.

Authors:  Gong Yang; Imelda Mercado-Uribe; Asha S Multani; Subrata Sen; Ie-Ming Shih; Kwong-Kwok Wong; David M Gershenson; Jinsong Liu
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

9.  ANRIL regulates the proliferation of human colorectal cancer cells in both two- and three-dimensional culture.

Authors:  Madoka Naemura; Toshiyuki Tsunoda; Yasutoshi Inoue; Haruna Okamoto; Senji Shirasawa; Yojiro Kotake
Journal:  Mol Cell Biochem       Date:  2015-12-26       Impact factor: 3.396

10.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.